1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, June 2015 (p20)

Biological Therapy Analysis & Statistics, June 2015 (p20)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

571-600 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Non-Hodgkin Lymphoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic ...

  • Industries : Cancer, Pathology
  • Countries : United States
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Chronic ...

  • Industries : Cancer, Pathology
  • Countries : United States
Multiple Sclerosis - Pipeline Review, H1 2015

Multiple Sclerosis - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Multiple Sclerosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. ...

  • Industries : Pathology, Mental Health
  • Countries : United States
HIV / AIDS - Pipeline Review, H1 2015

HIV / AIDS - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

HIV / AIDS - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2015’, provides an overview of the HIV / AIDS’s therapeutic pipeline. This report provides ...

  • Industries : Therapy, Pharmaceutical, Biotechnology, Biopharmaceutical, Biological Therapy
  • Countries : United States
Hepatitis B - Pipeline Review, H1 2015

Hepatitis B - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Hepatitis B - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Hepatitis B - Pipeline Review, H1 2015’, provides an overview of the Hepatitis B’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015

Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Amyotrophic Lateral ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Ischemia - Pipeline Review, H1 2015

Ischemia - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Ischemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ischemia - Pipeline Review, H1 2015’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Therapy, Chronic Disease, Pathology, Pharmaceutical, Biological Therapy
  • Countries : United States
Ovarian Cancer - Pipeline Review, H1 2015

Ovarian Cancer - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report ...

  • Industries : Cancer, Pathology
  • Countries : United States
Melanoma - Pipeline Review, H1 2015

Melanoma - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Melanoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, ...

  • Industries : Cancer, Pathology
  • Countries : United States
Prostate Cancer - Pipeline Review, H1 2015

Prostate Cancer - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Prostate Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This ...

  • Industries : Cancer, Pathology
  • Countries : United States
Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • June 2015
  • by Global Markets Direct

Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Inovio ...

  • Industries : Biopharmaceutical, Pharmaceutical, Therapy, Biotechnology, Biological Therapy, Research and Development
  • Countries : United States
Rheumatoid Arthritis - Pipeline Review, H1 2015

Rheumatoid Arthritis - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Rheumatoid Arthritis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Parkinson%s Disease - Pipeline Review, H1 2015

Parkinson%s Disease - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Parkinson's Disease - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2015’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Age Related Macular Degeneration - Pipeline Review, H1 2015

Age Related Macular Degeneration - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2015’, provides an overview of the Age Related ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015

Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Data

Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015" provides an overview ...

  • Industries : Drug Discovery and Development, Biopharmaceutical, Biological Therapy, Therapy, Pharmaceutical, Biotechnology
  • Countries : World
Bioheart, Inc. - Product Pipeline Review - 2015

Bioheart, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • June 2015
  • by Global Markets Direct

Bioheart, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Bioheart, Inc. - Product Pipeline Review - 2015’, provides an overview of the Bioheart, Inc.’s pharmaceutical ...

  • Industries : Biological Therapy
  • Countries : United States
InteRNA Technologies B.V. - Product Pipeline Review - 2015

InteRNA Technologies B.V. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • June 2015
  • by Global Markets Direct

InteRNA Technologies B.V. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘InteRNA Technologies B.V. - Product Pipeline Review - 2015’, provides an overview of the InteRNA Technologies ...

  • Industries : Biological Therapy, Research and Development, Biotechnology
  • Countries : World
Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2015

Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • June 2015
  • by Global Markets Direct

Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2015’, provides an overview of ...

  • Industries : Biological Therapy
  • Countries : United States
RNAi for Therapeutic Applications: Technology and Market Forecast 2015-2025: Prospects for siRNAs, shRNAs and ddRNAi Approaches

RNAi for Therapeutic Applications: Technology and Market Forecast 2015-2025: Prospects for siRNAs, shRNAs and ddRNAi Approaches

  • $ 2 623
  • Industry report
  • June 2015
  • by Visiongain

Report Details RNAi therapies – new study showing you trends, R&D progress, and predicted revenues When will RNAi therapies reach the market? Visiongain’s brand new report shows you potential revenues ...

  • Industries : Biological Therapy, Therapy
  • Countries : World
2015-2019 Global Cell Surface Markers Testing Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

2015-2019 Global Cell Surface Markers Testing Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

  • $ 3 500
  • Industry report
  • June 2015
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : Spain, France, Italy, United Kingdom, Japan, Germany
2015-2019 European Cell Surface Markers Testing: Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Spain, UK

2015-2019 European Cell Surface Markers Testing: Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Spain, UK

  • $ 2 500
  • Industry report
  • June 2015
  • by Venture Planning Group

Complete report $3,850.  DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, ...

  • Industries : Biological Therapy
  • Countries : Spain, France, Italy, United Kingdom, Germany, Europe
Acute Lung Injury - Pipeline Review, H1 2015

Acute Lung Injury - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Acute Lung Injury - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acute Lung Injury - Pipeline Review, H1 2015’, provides an overview of the Acute Lung Injury’s therapeutic pipeline. ...

  • Industries : Chronic Disease, Pathology, Therapy
  • Countries : United States
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2015

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2015’, provides an overview of the Retinitis Pigmentosa ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biological Therapy
  • Countries : United States
Transplantation Global Clinical Trials Review, H1, 2015

Transplantation Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Data

Transplantation Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Transplantation Global Clinical Trials Review, H1, 2015" provides an overview of Transplantation clinical ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Biological Therapy, Healthcare, General Medicine and Specialty Medicine, Drug Discovery and Development, Pharmaceutical, Biotechnology
  • Countries : World
Future Horizons and Growth Strategies in the Global Cell Surface Testing Market 2015: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Cell Surface Testing Market 2015: Supplier Shares and Country Forecasts

  • $ 3 500
  • Industry report
  • June 2015
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : Spain
Future Horizons and Growth Strategies in the European Cell Surface Marker Testing Market 2015: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the European Cell Surface Marker Testing Market 2015: Supplier Shares and Country Forecasts

  • $ 2 500
  • Industry report
  • June 2015
  • by Venture Planning Group

Complete report $3,850.  DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, ...

  • Industries : Biological Therapy
  • Countries : Spain, France, Italy, United Kingdom, Germany
Future Horizons and Growth Strategies in the US Cell Surface Marker Testing Market 2015: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the US Cell Surface Marker Testing Market 2015: Supplier Shares and Country Forecasts

  • $ 1 450
  • Industry report
  • June 2015
  • by Venture Planning Group

Complete report $2,250.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
Immuno-Oncology Overview

Immuno-Oncology Overview

  • $ 7 500
  • Industry report
  • June 2015
  • by Datamonitor Healthcare

This is an overview of the field of immuno-oncology and the various immuno-oncology classes Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well as one of ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : United States
Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2015 Update

Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • June 2015
  • by Global Data

Summary Cytograft Tissue Engineering, Inc. (CTE) is a genetic engineering company that offers therapies. The company develops cell-based therapies to repair and rebuild diseased tissues and organs. It ...

  • Industries : Biological Therapy, Genomics, Cardiovascular Devices
  • Countries : World
About 3 200 reports

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in the US

  • June 2016
    12 pages
  • Biological Ther...  

  • United States  

View report >

Cytokine Industry

June 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.